Localization of acidic fibroblast growth factor, fibroblast growth factor receptor-4, transforming growth factor-alpha, and epidermal growth factor receptor in human endocrine cells of the gut and related tumors: An immunohistochemical study
S. La Rosa et al., Localization of acidic fibroblast growth factor, fibroblast growth factor receptor-4, transforming growth factor-alpha, and epidermal growth factor receptor in human endocrine cells of the gut and related tumors: An immunohistochemical study, APPL IMMUNO, 6(4), 1998, pp. 199-208
Gastrointestinal endocrine tumors (GETs) are neoplasms of uncertain etiopat
hogenesis that often show a prominent fibroblast and smooth muscle cell pro
liferation within the tumor stroma. Acidic fibroblast growth factor (aFGF)
and transforming growth factor-alpha (TGF alpha) are potent mitogens for bo
th mesenchymal and epithelial cells, and their biologic activities depend o
n binding to specific receptors, including fibroblast growth factor recepto
r-4 (FGFR4) and epidermal growth factor receptor (EGFR). To evaluate the ro
les of these growth factors and their respective receptors in the pathogene
sis of stromal lesions and tumor growth, we investigated their immunohistoc
hemical expression in 43 normal gastrointestinal mucosa samples and 53 GETs
. aFGF expression was found in a subgroup of enterochromaffin (EC) cells of
the gastric and intestinal mucosa, whereas FGFR4 was localized only in col
orectal L cells. TGF alpha was expressed in intestinal EC cells and colorec
tal L cells, whereas EGFR was not detected in any gut endocrine cell. aFGF
was localized in all EC-cell neoplasms and was coexpressed with FGFR4 in mo
st cases. This receptor was also found in all L-cell tumors and in a few of
the other types of GETs. EGFR was not detected in any of the GETs examined
. Several stromal cells of GETs, including fibroblasts and smooth muscle ce
lls, showed FGFR4 and EGFR immunoreactivity. Tumors expressing both aFGF an
d TGF alpha presented a stroma that was more abundant than that of GETs exp
ressing none or only one of these factors. These results suggest that FGFR4
expression may be involved in the development of EC-cell tumors through an
autocrine mechanism, and that the abundant fibromuscular stroma may be rel
ated to the concurrent production of both aFGF and TGF alpha by tumor cells
.